Keep this in mind that the China company which just invested $5M in ORMP has $200M cash on book and near $200M profit per year. They might want to invest much more than $5M in ORMP in the future if the Phase IIb finished well. They could even easily take over the whole company if they really want.
Also there are many similar medical China companies like this one seeking investment opportunities on the market, this one might be just the beginning.
But maybe they would like to take 20% of the float of ORMP at least, who knows.
Even though, I would still be very cautious on this stock due to its high risk on drug approval etc.
A lot of shorts and day traders are on this stock so it would be always violent if you watched how
it went from $33 to $8 this year. So safe investment is the first concern, I only have 10% position on this so far.